Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

People with alopecia areata are more likely to have other immune-related conditions.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

The study suggests that hypothyroidism may cause alopecia areata.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Dupilumab users have a higher risk of developing alopecia areata.

Having asthma, atopic dermatitis, or Hashimoto's thyroiditis increases the risk of severe and long-lasting alopecia areata.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

TNF-alpha inhibitors can cause various immune-related skin issues.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Dupilumab may cause hair loss, so patients should be monitored.

Upadacitinib improved multiple immune-related conditions in one patient.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Diet can influence inflammatory skin diseases.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

Celiac disease can cause skin problems that may get better with a gluten-free diet.